Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
for
Neurological Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT03922555
Phase 1, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Boston MA, Providence RI, Lebanon NH, Hackensack NJ,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase 3, Recruiting
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
for
Breast Atypical Ductal Hyperplasia,
Location: Boston MA, Cleveland OH, Ann Arbor MI, Charleston SC,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18 - 55
Code: NCT06184750
Phase 2, Recruiting
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
for
Melanoma, Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, New Haven CT, Richmond VA
Sponsor: IO Biotech
Sex: All
Age: 18+
Code: NCT05280314
Phase 2, Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Location: Fall River MA, Fairhaven MA, Scarborough ME,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06758401
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Onyx™ Liquid Embolic IDE Clinical Study
for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Boston MA, New Haven CT, Albany NY, New York NY,
Sponsor: Medtronic Endovascular
Sex: All
Age: 22+
Code: NCT06742801
Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
for
Advanced Malignant Solid Neoplasm,
Location: Boston MA, New Haven CT, Trumbull CT, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06311214
Phase 2, Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT05235165
Phase 3, Recruiting
A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US
for
Immunoglobulin A Nephropathy
Location: Boston MA
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06952426
Recruiting
Avo In R/R And Previously Untreated MCL
for
Mantle Cell Lymphoma, Refractory Lymphoma
Location: Boston MA, Chicago IL
Sponsor: Austin I Kim
Sex: All
Age: 18+
Code: NCT04855695
Phase 1, Phase 2, Recruiting
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
for
Barretts Esophagus With Dysplasia, Barrett Esophagus,
Location: Boston MA, Lebanon NH, Manhasset NY, New York NY,
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT05753748
Recruiting
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
for
Acromegaly
Location: Boston MA, New York NY, Philadelphia PA, Cleveland OH,
Sponsor: Debiopharm International SA
Sex: All
Age: 18+
Code: NCT06930625
Phase 3, Recruiting
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
for
T-Cell Lymphoma
Location: Boston MA, New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05313243
Phase 2, Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
for
Parkinsons Disease (PD)
Location: Boston MA, Providence RI, New York NY, Burlington VT,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 45 - 70+
Code: NCT06944522
Phase 3, Recruiting
Remote Fetal Monitoring in High Risk Pregnancies
for
High Risk Pregnancy, Remote Patient Monitoring, Diabetes,
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center
Sex: Female
Age: 18+
Code: NCT06822439
Recruiting
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Boston MA, Hackensack NJ, New York NY, Buffalo NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06121843
Phase 1, Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Providence RI, Boston MA, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03972657
Phase 1, Phase 2, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Boston MA, Bronx NY, New York NY, Hackensack NJ,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase 3, Recruiting
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
for
Non-muscle-invasive Bladder Cancer
Location: Boston MA, Annapolis MD, Troy MI, Columbus OH,
Sponsor: SURGE Therapeutics
Sex: All
Age: 18+
Code: NCT05710848
Phase 1, Phase 2, Recruiting
Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors